These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10904872

  • 1. Characterization of a new animal model for human renal cell carcinoma.
    Pulkkanen KJ, Parkkinen JJ, Kettunen MI, Kauppinen RA, Lappalainen M, Ala-Opas MY, Yla-Herttuala S.
    In Vivo; 2000; 14(3):393-400. PubMed ID: 10904872
    [Abstract] [Full Text] [Related]

  • 2. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Ki-67 in a renal cell carcinoma severe combined immunodeficiency disease mouse model is associated with induction of apoptosis and tumour growth inhibition.
    Kausch I, Jiang H, Ewerdwalbesloh N, Doehn C, Krüger S, Sczakiel G, Jocham D.
    BJU Int; 2005 Feb; 95(3):416-20. PubMed ID: 15679806
    [Abstract] [Full Text] [Related]

  • 4. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice.
    Naito S, von Eschenbach AC, Giavazzi R, Fidler IJ.
    Cancer Res; 1986 Aug; 46(8):4109-15. PubMed ID: 3731078
    [Abstract] [Full Text] [Related]

  • 5. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
    Sato H, Senba H, Virgona N, Fukumoto K, Ishida T, Hagiwara H, Negishi E, Ueno K, Yamasaki H, Yano T.
    Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
    [Abstract] [Full Text] [Related]

  • 6. Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice.
    Naito S, von Eschenbach AC, Fidler IJ.
    J Natl Cancer Inst; 1987 Feb; 78(2):377-85. PubMed ID: 3468299
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238.
    Plonowski A, Schally AV, Nagy A, Kiaris H, Hebert F, Halmos G.
    Cancer Res; 2000 Jun 01; 60(11):2996-3001. PubMed ID: 10850448
    [Abstract] [Full Text] [Related]

  • 8. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K, Cheale M, Coleman N, Fox SB.
    Clin Cancer Res; 2002 Apr 01; 8(4):1075-81. PubMed ID: 11948116
    [Abstract] [Full Text] [Related]

  • 9. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
    Weber KL, Doucet M, Price JE, Baker C, Kim SJ, Fidler IJ.
    Cancer Res; 2003 Jun 01; 63(11):2940-7. PubMed ID: 12782601
    [Abstract] [Full Text] [Related]

  • 10. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL, Pathak S, Multani AS, Price JE.
    J Urol; 2002 Aug 01; 168(2):774-9. PubMed ID: 12131367
    [Abstract] [Full Text] [Related]

  • 11. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ, Liu H, Hwang DH, Kawamoto H, Scherr DS.
    Urology; 2009 May 01; 73(5):1156-62. PubMed ID: 19118885
    [Abstract] [Full Text] [Related]

  • 12. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y, Matsuoka Y, Bazille C, Christensen EI, Ronco P, Debiec H.
    Clin Cancer Res; 2005 Feb 01; 11(3):1190-7. PubMed ID: 15709188
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of a renal cell carcinoma cell line (FU-UR-1) with the reciprocal ASPL-TFE3 fusion transcript.
    Ishiguro M, Iwasaki H, Ohjimi Y, Kaneko Y.
    Oncol Rep; 2004 Jun 01; 11(6):1169-75. PubMed ID: 15138551
    [Abstract] [Full Text] [Related]

  • 14. [Ki-67 antisense therapy in murine renal cell carcinoma models].
    Kausch I, Jiang H, Brocks C, Albers A, Krüger S, Sczakiel G, Jocham D.
    Aktuelle Urol; 2005 Apr 01; 36(2):142-8. PubMed ID: 15902575
    [Abstract] [Full Text] [Related]

  • 15. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F, Rasmussen LM, Tilton R, Denner L, Flyvbjerg A.
    Anticancer Res; 2003 Apr 01; 23(2B):1625-30. PubMed ID: 12820432
    [Abstract] [Full Text] [Related]

  • 16. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E, Sato H, Nagashima Y, Negishi E, Shirai S, Fukumoto K, Hagiwara H, Hagiwara K, Ueno K, Yano T.
    Life Sci; 2005 Apr 22; 76(23):2711-20. PubMed ID: 15792837
    [Abstract] [Full Text] [Related]

  • 17. Laminin alpha1 chain in human renal cell carcinomas and integrin-mediated adhesion of renal cell carcinoma cells to human laminin isoforms.
    Rissanen J, Korhonen M, Lehto VP, Virtanen I.
    J Pathol; 2003 Jun 22; 200(2):157-67. PubMed ID: 12754736
    [Abstract] [Full Text] [Related]

  • 18. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B, Eble JN, McCredie MR, Bethwaite PB, Stewart JH, Bilous AM.
    Hum Pathol; 2001 Jun 22; 32(6):590-5. PubMed ID: 11431713
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.